Inflammasomes in cancer: a double-edged sword

Abstract

Chronic inflammatory responses have long been observed to be associated with various types of cancer and play decisive roles at different stages of cancer development. Inflammasomes, which are potent inducers of interleukin (IL)-1β and IL-18 during inflammation, are large protein complexes typically consisting of a Nod-like receptor (NLR), the adapter protein ASC, and Caspase-1. During malignant transformation or cancer therapy, the inflammasomes are postulated to become activated in response to danger signals arising from the tumors or from therapy-induced damage to the tumor or healthy tissue. The activation of inflammasomes plays diverse and sometimes contrasting roles in cancer promotion and therapy depending on the specific context. Here we summarize the role of different inflammasome complexes in cancer progression and therapy. Inflammasome components and pathways may provide novel targets to treat certain types of cancer; however, using such agents should be cautiously evaluated due to the complex roles that inflammasomes and proinflammatory cytokines play in immunity.

Keywords

inflammasome / cancer / inflammation

References

[1] AllenIC, TeKippeEM, WoodfordRM, UronisJM, HollEK, RogersAB, HerfarthHH, JobinC, TingJP (2010) The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med207: 1045-1056

[2] AllenIC, WilsonJE, SchneiderM, LichJD, RobertsRA, ArthurJC, WoodfordRM, DavisBK, UronisJM, HerfarthHH (2012) NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity36: 742-754

[3] BassoD, ScrignerM, TomaA, NavagliaF, Di MarioF, RuggeM, PlebaniM (1996) Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2. Int J Clin Lab Res26: 207-210

[4] BauerC, DuewellP, MayerC, LehrHA, FitzgeraldKA, DauerM, TschoppJ, EndresS, LatzE, SchnurrM (2010) Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut59: 1192-1199

[5] BauernfeindF, HornungV (2013) Of inflammasomes and pathogens -sensing of microbes by the inflammasome. EMBO Mol Med5: 814-826

[6] BauernfeindFG, HorvathG, StutzA, AlnemriES, MacDonaldK, SpeertD, Fernandes-AlnemriT, WuJ, MonksBG, FitzgeraldKA (2009) Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol183: 787-791

[7] BauernfeindF, AblasserA, BartokE, KimS, Schmid-BurgkJ, CavlarT, HornungV (2011) Inflammasomes: current understanding and open questions. Cell Mol Life Sci68: 765-783

[8] BuntSK, ClementsVK, HansonEM, SinhaP, Ostrand-RosenbergS (2009) Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4. J Leukoc Biol85: 996-1004

[9] BurdetteD, HaskettA, PresserL, McRaeS, IqbalJ, WarisG (2012) Hepatitis C virus activates interleukin-1beta via caspase-1- inflammasome complex. J Gen Virol93: 235-246

[10] ChaveyC, BibeauF, Gourgou-BourgadeS, BurlinchonS, BoissiereF, LauneD, RoquesS, LazennecG (2007) Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res9: R15

[11] ChenGY, NunezG (2011) Inflammasomes in intestinal inflammation and cancer. Gastroenterology141: 1986-1999

[12] ChenGY, LiuM, WangF, BertinJ, NunezG (2011) A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J Immunol186: 7187-7194

[13] ChowMT, SceneayJ, PagetC, WongCS, DuretH, TschoppJ, MollerA, SmythMJ (2012) NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases. Cancer Res72: 5721-5732

[14] CoussensLM, ZitvogelL, PaluckaAK (2013) Neutralizing tumorpromoting chronic inflammation: a magic bullet? Science339: 286-291

[15] Di VirgilioF (2013) The therapeutic potential of modifying inflammasomes and NOD-Like receptors. Pharmacol Rev65: 872-905

[16] DinarelloCA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol27: 519-550

[17] DinarelloCA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood117: 3720-3732

[18] DostertC, PetrilliV, Van BruggenR, SteeleC, MossmanBT, TschoppJ (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science320: 674-677

[19] DrexlerSK, BonsignoreL, MasinM, TardivelA, JackstadtR, HermekingH, SchneiderP, GrossO, TschoppJ, YazdiAS (2012) Tissue-speciflc opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis. Proc Natl Acad Sci USA109: 18384-18389

[20] DunnJH, EllisLZ, FujitaM (2012) Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma. Cancer Lett314: 24-33

[21] Dupaul-ChicoineJ, YeretssianG, DoironK, BergstromKS, McIntireCR, LeBlancPM, MeunierC, TurbideC, GrosP, BeaucheminN (2010) Control of intestinal homeostasis, colitis, and colitisassociated colorectal cancer by the inflammatory caspases. Immunity32: 367-378

[22] EisenbarthSC, FlavellRA (2009) Innate instruction of adaptive immunity revisited: the inflammasome. EMBO Mol Med1: 92-98

[23] ElinavE, StrowigT, KauAL, Henao-MejiaJ, ThaissCA, BoothCJ, PeaperDR, BertinJ, EisenbarthSC, GordonJI (2011) NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell145: 745-757

[24] ElkabetsM, RibeiroVS, DinarelloCA, Ostrand-RosenbergS, Di SantoJP, ApteRN, VosshenrichCA (2010) IL-1beta regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function. Eur J Immunol40: 3347-3357

[25] ElliottMR, ChekeniFB, TrampontPC, LazarowskiER, KadlA, WalkSF, ParkD, WoodsonRI, OstankovichM, SharmaP (2009) Nucleotides released by apoptotic cells act as a flnd-me signal to promote phagocytic clearance. Nature461: 282-286

[26] El-OmarEM, CarringtonM, ChowWH, McCollKE, BreamJH, YoungHA, HerreraJ, LissowskaJ, YuanCC, RothmanN (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature404: 398-402

[27] Fernandes-AlnemriT, YuJW, DattaP, WuJ, AlnemriES (2009) AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature458: 509-513

[28] Fernandes-AlnemriT, YuJW, JulianaC, SolorzanoL, KangS, WuJ, DattaP, McCormickM, HuangL, McDermottE (2010) The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol11: 385-393

[29] FerroneC, DranoffG (2010) Dual roles for immunity in gastrointestinal cancers. J Clin Oncol28: 4045-4051

[30] FranchiL, NunezG (2012) Immunology. Orchestrating inflammasomes. Science337: 1299-1300

[31] FranchiL, AmerA, Body-MalapelM, KannegantiTD, OzorenN, JagirdarR, InoharaN, VandenabeeleP, BertinJ, CoyleA (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol7: 576-582

[32] GhiringhelliF, ApetohL, TesniereA, AymericL, MaY, OrtizC, VermaelenK, PanaretakisT, MignotG, UllrichE (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med15: 1170-1178

[33] GreenDR, KroemerG (2005) Pharmacological manipulation of cell death: clinical applications in sight? J Clin Invest115: 2610-2617

[34] GringhuisSI, KapteinTM, WeversBA, TheelenB, van der VlistM, BoekhoutT, GeijtenbeekTB (2012) Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1beta via a noncanonical caspase-8 inflammasome. Nat Immunol13: 246-254

[35] GrivennikovSI, GretenFR, KarinM (2010) Immunity, inflammation, and cancer. Cell140: 883-899

[36] HornungV, AblasserA, Charrel-DennisM, BauernfeindF, HorvathG, CaffreyDR, LatzE, FitzgeraldKA (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature458: 514-518

[37] HuB, ElinavE, HuberS, BoothCJ, StrowigT, JinC, EisenbarthSC, FlavellRA (2010) Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci USA107: 21635-21640

[38] HuB, ElinavE, FlavellRA (2011) Inflammasome-mediated suppression of inflammation-induced colorectal cancer progression is mediated by direct regulation of epithelial cell proliferation. Cell Cycle10: 1936-1939

[39] IdzkoM, DichmannS, FerrariD, Di VirgilioF, la SalaA, GirolomoniG, PantherE, NorgauerJ (2002) Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood100: 925-932

[40] IyerSS, PulskensWP, SadlerJJ, ButterLM, TeskeGJ, UllandTK, EisenbarthSC, FlorquinS, FlavellRA, LeemansJC (2009) Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA106: 20388-20393

[41] JeeCD, LeeHS, BaeSI, YangHK, LeeYM, RhoMS, KimWH (2005) Loss of caspase-1 gene expression in human gastric carcinomas and cell lines. Int J Oncol26: 1265-1271

[42] JinL, YuanRQ, FuchsA, YaoY, JosephA, SchwallR, SchnittSJ, GuidaA, HastingsHM, AndresJ (1997) Expression of interleukin-1beta in human breast carcinoma. Cancer80: 421-434

[43] JulianaC, Fernandes-AlnemriT, KangS, FariasA, QinF, AlnemriES (2012) Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J Biol Chem287: 36617-36622

[44] KanavyHE, GerstenblithMR (2011) Ultraviolet radiation and melanoma. Semin Cutan Med Surg30: 222-228

[45] KayagakiN, WarmingS, LamkanflM, Vande WalleL, LouieS, DongJ, NewtonK, QuY, LiuJ, HeldensS (2011) Non-canonical inflammasome activation targets caspase-11. Nature479: 117-121

[46] KimS, BauernfeindF, AblasserA, HartmannG, FitzgeraldKA, LatzE, HornungV (2010) Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome. Eur J Immunol40: 1545-1551

[47] LamkanflM, DixitVM (2009) The inflammasomes. PLoS Pathog5: e1000510

[48] LiY, WangL, PappanL, Galliher-BeckleyA, ShiJ (2012) IL-1beta promotes stemness and invasiveness of colon cancer cells through Zeb1 activation. Mol Cancer11: 87

[49] LiuX, WangZ, YuJ, LeiG, WangS (2010) Three polymorphisms in interleukin-1beta gene and risk for breast cancer: a metaanalysis. Breast Cancer Res Treat124: 821-825

[50] LiuW, LuoY, DunnJH, NorrisDA, DinarelloCA, FujitaM (2013) Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma. J Invest Dermatol133: 518-527

[51] LocherC, ConfortiR, AymericL, MaY, YamazakiT, RusakiewiczS, TesniereA, GhiringhelliF, ApetohL, MorelY (2010) Desirable cell death during anticancer chemotherapy. Ann N Y Acad Sci1209: 99-108

[52] MachadoJC, PharoahP, SousaS, CarvalhoR, OliveiraC, FigueiredoC, AmorimA, SerucaR, CaldasC, CarneiroF (2001) Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology121: 823-829

[53] MariathasanS, NewtonK, MonackDM, VucicD, FrenchDM, LeeWP, Roose-GirmaM, EricksonS, DixitVM (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature430: 213-218

[54] MariathasanS, WeissDS, NewtonK, McBrideJ, O’RourkeK, Roose-GirmaM, LeeWP, WeinrauchY, MonackDM, DixitVM (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature440: 228-232

[55] MartinonF, PetrilliV, MayorA, TardivelA, TschoppJ (2006) Goutassociated uric acid crystals activate the NALP3 inflammasome. Nature440: 237-241

[56] MartinsI, TesniereA, KeppO, MichaudM, SchlemmerF, SenovillaL, SerorC, MetivierD, PerfettiniJL, ZitvogelL (2009) Chemotherapy induces ATP release from tumor cells. Cell Cycle8: 3723-3728

[57] MattarolloSR, LoiS, DuretH, MaY, ZitvogelL, SmythMJ (2011) Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors. Cancer Res71: 4809-4820

[58] McNamaraD, El-OmarE (2008) Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions. Dig Liver Dis40: 504-509

[59] MiaoEA, Alpuche-ArandaCM, DorsM, ClarkAE, BaderMW, MillerSI, AderemA (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol7: 569-575

[60] MiaoEA, ErnstRK, DorsM, MaoDP, AderemA (2008) Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc Natl Acad Sci USA105: 2562-2567

[61] MiaoEA, RajanJV, AderemA (2011) Caspase-1-induced pyroptotic cell death. Immunol Rev243: 206-214

[62] NegashAA, RamosHJ, CrochetN, LauDT, DoehleB, PapicN, DelkerDA, JoJ, BertolettiA, HagedornCH (2013) IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog9: e1003330

[63] NormandS, Delanoye-CrespinA, BressenotA, HuotL, GrandjeanT, Peyrin-BirouletL, LemoineY, HotD, ChamaillardM (2011) Nodlike receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci USA108: 9601-9606

[64] OkamotoM, LiuW, LuoY, TanakaA, CaiX, NorrisDA, DinarelloCA, FujitaM (2010) Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem285: 6477-6488

[65] PantschenkoAG, PushkarI, AndersonKH, WangY, MillerLJ, KurtzmanSH, BarrowsG, KreutzerDL (2003) The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression. Int J Oncol23: 269-284

[66] RamanD, BaugherPJ, ThuYM, RichmondA (2007) Role of chemokines in tumor growth. Cancer Lett256: 137-165

[67] RathinamVA, JiangZ, WaggonerSN, SharmaS, ColeLE, WaggonerL, VanajaSK, MonksBG, GanesanS, LatzE (2010) The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol11: 395-402

[68] ReedJR, LeonRP, HallMK, SchwertfegerKL (2009) Interleukin-1beta and flbroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis. Breast Cancer Res11:R21

[69] SagulenkoV, ThygesenSJ, SesterDP, IdrisA, CridlandJA, VajjhalaPR, RobertsTL, SchroderK, VinceJE, HillJM (2013) AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ20: 1149-1160

[70] SakuraiT, HeG, MatsuzawaA, YuGY, MaedaS, HardimanG, KarinM (2008) Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell14: 156-165

[71] SalcedoR, WorschechA, CardoneM, JonesY, GyulaiZ, DaiRM, WangE, MaW, HainesD, O’HUiginC (2010) MyD88- mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med207: 1625-1636

[72] SchroderK, TschoppJ (2010) The inflammasomes. Cell140: 821-832

[73] SchroderK, SagulenkoV, ZamoshnikovaA, RichardsAA, CridlandJA, IrvineKM, StaceyKJ, SweetMJ (2012) Acute lipopolysaccharide priming boosts inflammasome activation independently of inflammasome sensor induction. Immunobiology217: 1325-1329

[74] SevkoA, UmanskyV (2013) Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves. J Cancer4: 3-11

[75] SiegmundB, LehrHA, FantuzziG, DinarelloCA (2001) IL-1 betaconverting enzyme (caspase-1) in intestinal inflammation. Proc Natl Acad Sci USA98: 13249-13254

[76] SnoussiK, StrosbergAD, BouaouinaN, Ben AhmedS, ChouchaneL (2005) Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma. Eur Cytokine Netw16: 253-260

[77] SrivastavaS, SalimN, RobertsonMJ (2010) Interleukin-18: biology and role in the immunotherapy of cancer. Curr Med Chem17: 3353-3357

[78] StehlikC, FiorentinoL, DorfleutnerA, BrueyJM, ArizaEM, SagaraJ, ReedJC (2002) The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways. J Exp Med196: 1605-1615

[79] SuzukiT, FranchiL, TomaC, AshidaH, OgawaM, YoshikawaY, MimuroH, InoharaN, SasakawaC, NunezG (2007) Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog3: e111

[80] TermeM, UllrichE, AymericL, MeinhardtK, DesboisM, DelahayeN, ViaudS, RyffelB, YagitaH, KaplanskiG (2011) IL-18 induces PD-1-dependent immunosuppression in cancer. Cancer Res71: 5393-5399

[81] TuS, BhagatG, CuiG, TakaishiS, Kurt-JonesEA, RickmanB, BetzKS, Penz-OesterreicherM, BjorkdahlO, FoxJG (2008) Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell14: 408-419

[82] van DeventerHW, BurgentsJE, WuQP, WoodfordRM, BrickeyWJ, AllenIC, McElvania-TekippeE, SerodyJS, TingJP (2010) The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells. Cancer Res70: 10161-10169

[83] WangP, XiaHH, ZhangJY, DaiLP, XuXQ, WangKJ (2007) Association of interleukin-1 gene polymorphisms with gastric cancer: a meta-analysis. Int J Cancer120: 552-562

[84] ZakiMH, BoydKL, VogelP, KastanMB, LamkanflM, KannegantiTD (2010a) The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity32: 379-391

[85] ZakiMH, VogelP, Body-MalapelM, LamkanflM, KannegantiTD (2010b) IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J Immunol185: 4912-4920

[86] ZakiMH, VogelP, MalireddiRK, Body-MalapelM, AnandPK, BertinJ, GreenDR, LamkanflM, KannegantiTD (2011) The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell20: 649-660

[87] ZamboniDS, KobayashiKS, KohlsdorfT, OguraY, LongEM, VanceRE, KuidaK, MariathasanS, DixitVM, FlavellRA (2006) The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat Immunol7: 318-325

[88] ZhuY, ZhuM, LanceP (2012) IL1beta-mediated Stromal COX-2 signaling mediates proliferation and invasiveness of colonic epithelial cancer cells. Exp Cell Res318: 2520-2530

[89] ZitvogelL, KeppO, GalluzziL, KroemerG (2012) Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol13: 343-351

RIGHTS & PERMISSIONS

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.